We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Asian Journal of Current Research in Clinical Cancer

2025 Volume 5 Issue 1

Clinical-Dermoscopic and Histopathologic Markers of Metastatic Risk in Early-Stage Thin Melanoma


, ,
  1. Department of Oncology, Faculty of Medicine, University of Quito, Quito, Ecuador.
Abstract

Although considered early lesions, thin cutaneous melanomas still account for a notable portion of melanoma-related deaths, and their incidence continues to rise. We carried out a retrospective case-control analysis to determine which clinical-dermoscopic and histologic variables correlate with local or distant spread in melanomas measuring ≤0.8 mm. Records from 1 January 2000 through 22 June 2022 were reviewed from two specialized Italian dermatologic oncology centers. Sixteen individuals with metastasizing ≤0.8 mm melanomas were compared with controls who remained metastasis-free for at least 5 years. Statistical testing used Pearson’s chi-square or Fisher’s exact test. Out of 1396 eligible melanomas, 1.1% eventually metastasized. The median age at diagnosis was 49 years (range 28-83), with 56.3% male and 43.7% female. Tumors most often arose on the trunk (43.7%). Clinically, lesions were predominantly pigmented and frequently >10 mm (73.3%) with ≥3 hues (80%). Dermoscopy most commonly showed white areas (73.3%), atypical vascular structures (66.5%), blue-gray zones (60%), and an absent pigment network (60%). Histopathology revealed universally unfavorable traits, including regression (87.4%), mitoses within the dermis (50%), vertical growth (62.5%), and ulceration (12.5%). All of these differed significantly from controls (p < 0.05). For melanomas ≤0.8 mm, certain clinical and dermoscopic indicators, when combined with adverse tissue findings, may point toward a greater chance of metastatic behavior.


How to cite this article
Vancouver
Reyes E, Ayala J, Benítez M. Clinical-Dermoscopic and Histopathologic Markers of Metastatic Risk in Early-Stage Thin Melanoma. Asian J Curr Res Clin Cancer. 2025;5(1):116-23. https://doi.org/10.51847/Rn3Khn21yH
APA
Reyes, E., Ayala, J., & Benítez, M. (2025). Clinical-Dermoscopic and Histopathologic Markers of Metastatic Risk in Early-Stage Thin Melanoma. Asian Journal of Current Research in Clinical Cancer, 5(1), 116-123. https://doi.org/10.51847/Rn3Khn21yH
Articles
Long-Term Survival Outcomes of Colorectal Cancer Survivors: An In-Depth Exploration
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Zhaobei Cai
Theoretical Model of Thiophene and Its Derivatives Interaction with BRCA-1
Asian Journal of Current Research in Clinical Cancer
Vol 4 Issue 2, 2024 | Lauro FigueroaValverde
Computational Evaluation of Dibenzo Compounds as Potential Dual Inhibitors of Androgen Receptor and 5α-Reductase
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 1, 2022 | Lauro FigueroaValverde
Tolerability of Chemoradiotherapy in Geriatric Patients with Pancreatic Cancer
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | İrem Sarıcanbaz
Environmental Impact of the Y-Isomer of HCH: Unveiling Its Role in Cancer Formation
Asian Journal of Current Research in Clinical Cancer
Vol 2 Issue 2, 2022 | Mata Uvaysovna Razhaeva
An Overview of Targeted Therapy Applications in Cancer Treatment
Asian Journal of Current Research in Clinical Cancer
Vol 5 Issue 1, 2025 | Yeuan Ting Lee

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.